J&J Faces Suit By 80 Chinese Families Over Baby Products
This article was originally published in PharmAsia News
Eighty Chinese families are considering a class action suit against Johnson & Johnson, alleging its baby products harmed their children. A legal support group of more than 50 lawyers representing the families said it would submit the cases to the courts in April. At issue are the company's baby bath products, with one batch found to have 1,4-dioxane, a substance unregulated in China. The State FDA and the General Administration of Quality Supervision, Inspection and Quarantine have disagreed over the level of suspect contents in the products. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.